NewLimit
NewLimit develops epigenetic reprogramming medicines designed to restore function in aging cells and treat age-related disease.
$435MSeries C
ParticipantHC
Human Capital
Activity from announced rounds
Activity in this selectionOct 25, 2026 · Biotech · Jan 1, 2026
Human Capital is the San Francisco investment firm connected by company and investor records to Buildots, Cloaked and The Boring Company.
Recorded funding activity
Buildots turns construction-site imagery into progress and schedule analysis. The Boring Company develops tunneling machines and underground transport, while Archive supplies creator-marketing tools. The histories retain the distinct company products and financing events.
Sources
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $435M 1 disclosed · full round size, not this investor’s share